Journal article · 2025 · Open access
The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine
Clinical Pharmacology & Therapeutics, 119(2), 318–321 · Published 21 December 2025 · DOI 10.1002/cpt.70180
In brief
“The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine” is a 2025 journal article by Charles Khouri and 7 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 13 citations as of 17 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Clinical Pharmacology & Therapeutics.
- Citations
- 13
- Most cited in
- 2026 (13)
- Field-weighted impact
- 6.36
- References
- 9
- Authors
- 8
Abstract
In recent years, different national and international regulatory authorities, notably the FDA, have made their adverse event repositories publicly available, offering user-friendly dashboards. This has led to a large increase in low-quality, poorly reported research using adverse event reporting databases (e.g., FDA's Adverse Event Reporting System [FAERS]). Such publications producing thousands of statistical associations erroneously presented as "safety signals" can create unscientifically grounded alarm with considerable impact on healthcare provider practices and patient behaviors.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Khouri, C., Hlavaty, A., Fusaroli, M., Joshi, N., Salvo, F., Bate, A., Pariente, A., & Raschi, E. (2025). The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine. Clinical Pharmacology & Therapeutics, 119(2), 318–321. https://doi.org/10.1002/cpt.70180
MLA 9
Khouri, Charles, et al. “The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine.” Clinical Pharmacology & Therapeutics, vol. 119, no. 2, 2025, pp. 318–321. https://doi.org/10.1002/cpt.70180.
Chicago
Khouri, Charles, Alex Hlavaty, Michele Fusaroli, Nitin Joshi, Francesco Salvo, Andrew Bate, Antoine Pariente, and Emanuel Raschi. 2025. “The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine.” Clinical Pharmacology & Therapeutics 119 (2): 318–321. https://doi.org/10.1002/cpt.70180.
Harvard
Khouri, C. et al. (2025) ‘The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine’, Clinical Pharmacology & Therapeutics, 119(2), pp. 318–321. doi:10.1002/cpt.70180.
IEEE
C. Khouri et al., “The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine,” Clinical Pharmacology & Therapeutics, vol. 119, no. 2, pp. 318–321, 2025, doi: 10.1002/cpt.70180.
BibTeX
@article{khouri2025rising,
title = {{The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine}},
author = {Khouri, Charles and Hlavaty, Alex and Fusaroli, Michele and Joshi, Nitin and Salvo, Francesco and Bate, Andrew and Pariente, Antoine and Raschi, Emanuel},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2025},
volume = {119},
number = {2},
pages = {318--321},
doi = {10.1002/cpt.70180},
url = {https://doi.org/10.1002/cpt.70180}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- pharmacovigilance
- FDA Adverse Event Reporting System
- safety signals
- evidence-based medicine
- regulatory agencies
- drug safety
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Khouri, C., Hlavaty, A., Fusaroli, M., Joshi, N., Salvo, F., Bate, A., Pariente, A., & Raschi, E. (2025). The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine. Clinical Pharmacology & Therapeutics, 119(2), 318–321. https://doi.org/10.1002/cpt.70180
How many times has this paper been cited?
13 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.
Who wrote this paper?
Charles Khouri, Alex Hlavaty, Michele Fusaroli, Nitin Joshi, Francesco Salvo, Andrew Bate, Antoine Pariente, Emanuel Raschi.
What is the DOI of this paper?
10.1002/cpt.70180, permanently at https://doi.org/10.1002/cpt.70180. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.